Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 8-K Event Other events
  5. SC 13G/A Stake Amended Statement of Ownership
  6. 4 Open-market sale EVP and CCO sold 27,250 shares at an average $56.25 ($1,532,786)
  7. 3 Insider Initial Statement of Ownership
  8. 8-K Event Executive or director change · Shareholder vote results
  9. 4 Grant or award Director acquired 12,236 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale President sold 82,295 shares at an average $50.03 ($4,117,244)
  15. 4 Open-market sale CEO sold 200,000 shares at an average $46.02 ($9,204,692)
  16. 4 Open-market sale Director sold 26,250 shares at $51.13 ($1,342,178)
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. CT ORDER Other Confidential Order
  20. 4 Open-market sale EVP & General Counsel sold 1,072 shares at $49.22 ($52,764)

Page 21 of 70 · 1,382 filings